Keywords
Anosmia
Smell
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To understand the clinical profile of patients with olfactory loss due to SARS-CoV-2 infection, as well as its persistence over the study period and the presence of possible associated factors. Methods: Initially, a questionnaire was collected via an online form in order to assess the patient's complaints, and then face-to-face assessments were carried out to perform olfactory tests in order to measure anosmia. Results: 75 patients were included in the study, 56 (75%) female and 19 (25%) male. Regarding the study of the sense of smell carried out face-to-face, it was observed that, as more evaluations were carried out, the better the patient's perception of this sense became. However, not all 75 patients in the sample were able to carry out all the suggested evaluations. Conclusion: The investigation for a better management of olfactory disorders must be continuous, as many questions remain uncertain, especially those related to pathophysiology, objective assessment of anosmia and its treatment.
References
ADDISON AB, et al. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory disfunction. The Journal of Allergy and Clinical Immunology, 2021; 147(5): 1704-1719.
BOESVELDT S. Anosmia – A Clinical Review. Chemical Senses – Oxford Academic, 2017; 42(7): 513-523.
BRANDÃO NETO D, et al. Chemosensory Dysfunction in COVID-19: Prevalences, Recovery Rates, and Clinical Associations on a Large Brazilian Sample. Otolaryngology – Head and Neck Surgery, 2021; 164(3): 512-518.
BRIDWELL R, et al. Neurologic complications of COVID-19. American Journal of Emergency Medicine, 2020; 38(7): 1549.e3-1549.e7.
CHEW SY, et al. Characteristics and Outcomes of COVID-19 Patients with Respiratory Failure Admitted to a "Pandemic Ready" Intensive Care Unit - Lessons from Singapore. Annals of the Academy of Medicine of Singapore, 2020; 47(7): 434-448.
DA SILVA JÚNIOR PR, et al. Anosmia and COVID-19: perspectives on its association and the pathophysiological mechanisms involved. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021; 57(1): 8.
ELLUL MA, et al. Neurological associations of COVID-19. The Lancet Neurology, 2020; 19(9): 767-783.
ATTEMS J, et al. Olfaction and Aging: A Mini-Review. Gerontology, 2015; 61: 485-490.
BEZERRA TFP, et al. Quality of life assessment septoplasty in patients with nasal obstruction. Brazilian Journal of Otorhinolaryngology, 2012; 78(3): 57-62.
OBESITY AND OVERWEIGHT. 2021. In: World Health Organization. Geneva, Switzerland. Disponível em: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. Acesso em: 2 jan. 2023.
ISENMANN S, et al. Stórungen der Chemosensorik bei COVID-19: Pathomechanismen und klinische Relevanz. Fortschritte der Neurologie – Psychiatrie, 2021; 89(6): 281-288.
KOBAYASHI M, et al. A new clinical olfactory function test: cross-cultural influence. Archives of Otolaryngology – Head & Neck Surgery, 2007; 133(4): 331-336.
KOYAMA S, et al. Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia. International Journal of Molecular Sciences, 2021; 22(16): 1-71.
LAS CASAS LIMA MH, et al. Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review. Brazilian Journal of Otorhinolaryngology, 2021; 1078: 1-10.
LECHIEN JR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology, 2020; 277(8): 2251-2261.
MLHAVE, M.; AGERGAARD, J.; WEJSE, C. Clinical Management of COVID-19 Patients – An Update. Seminars in Nuclear Medicine, 2022; 52(1): 4-10.
MASTRANGELO A, et al. Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes. Neuroscience Letters, 2021; 748: 1-6.
MEHRAEEN E, et al. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. European Archives of Oto-Rhino-Laryngology, 2020; 278(2): 307-312.
NAJAFLOO R, et al. Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments. ACS Chemical Neuroscience, 2021; 12(20): 3795-3805.
TRECCA, E. M. C., et al. Results from psychophysical tests of smell and taste during the course of SARS-CoV-2 infection: a review. Acta Otorhinolaryngologica Italica, 2022; 42(1): 20-35.
VERONESE S e SBARBATI A. Chemosensory Systems in COVID-19: Evolution of Scientific Research. ACS Chemical Neuroscience, 2021; 12(5): 813-824.
VILLWOCK JA, et al. Affordable Rapid Olfaction Measurement Array: A Novel, essential oil-based test strongly correlated with UPSIT and subjective outcome measures. Annals of Otology, Rhinology & Laryngology, 2020; 129(1): 39-45.
ZAZHYTSKA M, et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell, 2022; 185(6): 1052-1064.